1. Home
  2. SOS vs UBX Comparison

SOS vs UBX Comparison

Compare SOS & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOS
  • UBX
  • Stock Information
  • Founded
  • SOS 2004
  • UBX 2009
  • Country
  • SOS China
  • UBX United States
  • Employees
  • SOS N/A
  • UBX N/A
  • Industry
  • SOS Finance: Consumer Services
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOS Finance
  • UBX Health Care
  • Exchange
  • SOS Nasdaq
  • UBX Nasdaq
  • Market Cap
  • SOS 17.0M
  • UBX 13.8M
  • IPO Year
  • SOS 2017
  • UBX 2018
  • Fundamental
  • Price
  • SOS $8.48
  • UBX $0.10
  • Analyst Decision
  • SOS
  • UBX Strong Buy
  • Analyst Count
  • SOS 0
  • UBX 3
  • Target Price
  • SOS N/A
  • UBX $4.67
  • AVG Volume (30 Days)
  • SOS 62.3K
  • UBX 1.9M
  • Earning Date
  • SOS 05-15-2025
  • UBX 08-05-2025
  • Dividend Yield
  • SOS N/A
  • UBX N/A
  • EPS Growth
  • SOS N/A
  • UBX N/A
  • EPS
  • SOS N/A
  • UBX N/A
  • Revenue
  • SOS $231,424,000.00
  • UBX N/A
  • Revenue This Year
  • SOS N/A
  • UBX N/A
  • Revenue Next Year
  • SOS N/A
  • UBX N/A
  • P/E Ratio
  • SOS N/A
  • UBX N/A
  • Revenue Growth
  • SOS 150.42
  • UBX N/A
  • 52 Week Low
  • SOS $4.04
  • UBX $0.10
  • 52 Week High
  • SOS $15.51
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • SOS 72.31
  • UBX 16.14
  • Support Level
  • SOS $6.06
  • UBX $0.24
  • Resistance Level
  • SOS $9.62
  • UBX $0.32
  • Average True Range (ATR)
  • SOS 0.62
  • UBX 0.09
  • MACD
  • SOS 0.29
  • UBX -0.06
  • Stochastic Oscillator
  • SOS 72.17
  • UBX 0.12

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: